Thromboembolic and bleeding complications in patients with oesophageal cancer.
Frits I MulderA HovenkampH W M van LaarhovenH R BüllerP W KamphuisenM C C M HulshofM I van Berge HenegouwenS MiddeldorpN van EsPublished in: The British journal of surgery (2020)
Patients with oesophageal cancer undergoing neoadjuvant chemoradiotherapy and surgery are at substantial risk of thromboembolic and bleeding events throughout all stages of treatment. Survival is worse in patients with thromboembolic events during follow-up.